Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Peter Wells, M.D.
Baylor Univ Medical Ctr Dallas, TX.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Alexandra Hospital
Edmonton, Alberta, Canada
- Victoria Cardiac Arrhythmia Trials, Inc.
Victoria, British Columbia, Canada
- London Health Sciences Centre
London, Ontario, Canada
- Hopital Du Sacre Coeur de Montreal
Montreal, Quebec, Canada
- Mcgill University Health Centre
Montreal, Quebec, Canada
- Montreal Heart Institute
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
- Prairie Cardiovascular Research Network
Regina, Saskatchewan, Canada
- Banner Good Samaritan Medical Center
Phoenix, Arizona, United States
- Pacific Heart Institute
Santa Monica, California, United States
- Stanford Hospital and Clinics
Stanford, California, United States
- Baptist Hospital of Miami
Miami, Florida, United States
- Orlando Regional Medical Center
Orlando, Florida, United States
- Piedmont Heart Institute
Atlanta, Georgia, United States
- Advocate Christ Medical Center
Oak Lawn, Illinois, United States
- Iowa Heart Center
Des Moines, Iowa, United States
- University of Michigan Medical Center
Ann Arbor, Michigan, United States
- Park Nicollet Institute
Saint Louis Park, Minnesota, United States
- Healtheast St. Joseph'S Hospital
Saint Paul, Minnesota, United States
- Southside Hospital
Bay Shore, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Sanger Heart and Vascular Institute
Charlotte, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Miami Valley Cardiologists
Dayton, Ohio, United States
- Sacred Heart Medical Center
Springfield, Oregon, United States
- Capital Cardiovascular Associates
Camp Hill, Pennsylvania, United States
- Geisinger Medical Center
Danville, Pennsylvania, United States
- Geisinger Wyoming Valley Medical Center
Wilkes-Barre, Pennsylvania, United States
- Wellmont Cardiovascular Heart Institute
Kingsport, Tennessee, United States
- Baylor Heart and Vascular Hospital
Dallas, Texas, United States
- St. Luke'S Episcopal
Houston, Texas, United States
- Baylor Research Institute
Plano, Texas, United States
- Virginia Heart
Falls Church, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2012
- Primary completion
- 30 Sept 2015
- Completion
- 30 Sept 2016
- Last update posted
- 13 Feb 2025
- Registered enrollment
- 572
- Registry id
- NCT01426425
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.